Table 1.
Correlations between EphB4 expression and clinicopathological features (n = 172)
| Variables | N | FSIP1+ | FSIP1– | P value |
|---|---|---|---|---|
| Age | 0.868 | |||
| ≤ 50 Y | 105 | 71 | 34 | |
| > 50 Y | 67 | 44 | 23 | |
| Tumor size | 0.070 | |||
| T1 | 70 | 41 | 29 | |
| T2, T3 | 102 | 74 | 28 | |
| Family history of cancer | 0.652 | |||
| Yes | 26 | 16 | 10 | |
| No | 146 | 99 | 47 | |
| Metastatic nodes | 0.001 | |||
| Positive | 86 | 68 | 18 | |
| Negative | 86 | 47 | 39 | |
| ER status | 0.007 | |||
| Positive | 65 | 49 | 16 | |
| Negative | 107 | 66 | 41 | |
| PR status | 0.041 | |||
| Positive | 70 | 52 | 18 | |
| Negative | 102 | 63 | 39 | |
| Her-2 status | 0.361 | |||
| Negative-+ | 111 | 70 | 41 | |
| ++ | 38 | 28 | 10 | |
| +++, ++++ | 23 | 17 | 6 | |
| TNM stage | 0.004 | |||
| II | 50 | 25 | 25 | |
| III, IV | 122 | 90 | 32 |